Skip to main content
Caplight Logo









Fusix Biotech

Fusix Biotech

Private
MunichHealthcare & Life Scienceshttps://fusixbiotech.de/

Last Round

Grant

Dec 13, 2023

Total Funding Raised

$1.73M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Fusix Biotech is a biotechnology company that is a developer of a cancer therapy designed for commercializing a novel fusion-based oncolytic viro-immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

oncolytic virus platformcancer immunotherapyimmuno-oncologysolid tumor therapyviral vector therapycancer-killing virusfusogenic cell deathpreclinical biotechgene therapybiologics developmenthepatocellular carcinomabiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fusix Biotech Comparables

Compare Fusix Biotech with similar companies based on industry and business-model similarity.

Fusix Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theolytics
79%
Circio Holding ASA
76%
Lokon Pharma
76%

Fusix Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 13, 2023
GrantSep 27, 2023
Pre SeedJul 1, 2022

Fusix Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 364% MoM, from 90 to 418.

  • May 19, 2026

    Monthly visitors increased 145% MoM.

Fusix Biotech Filings

Explore SEC and related filing metadata, where available.

Fusix Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fusix Biotech's valuation, stock price, and market status.

Is Fusix Biotech a public or private company?

Fusix Biotech is a private company.

What is the current stock price of Fusix Biotech?

Fusix Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Fusix Biotech worth (valuation)?

Valuation information for Fusix Biotech is not publicly available.

Can I buy Fusix Biotech stock?

Fusix Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fusix Biotech's last funding round?

Fusix Biotech's most recent funding round was Grant on December 13, 2023.

Who are the main investors in Fusix Biotech?

Key investors in Fusix Biotech include BlueYard Capital.

Will Fusix Biotech IPO soon?

No public IPO plans have been announced for Fusix Biotech.

How can I track Fusix Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fusix Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range3
Year Founded2022
Last FundingDec 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?